Skip to content
10-K

Annual Report

RALLYBIO CORPORATION RLYB

0001739410-25-000040

← back to feed
Filed
Mar 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 7, 2025 41.61M sh
Capex FY 2024 · Dec 31, 2024 $0
Capex FY 2024 · Dec 31, 2023 $12K
Shares Diluted FY 2024 · Dec 31, 2023 40.45M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$60.27M
Cash And Equivalents FY 2024 · Dec 31, 2023 $24.49M
Current Liabilities FY 2024 · Dec 31, 2023 $9.26M
Total Liabilities FY 2024 · Dec 31, 2023 $9.44M
Current Assets FY 2024 · Dec 31, 2023 $114.79M
Total Assets FY 2024 · Dec 31, 2023 $115.62M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.84
Eps Basic FY 2024 · Dec 31, 2023 −$1.84
Sga Expense FY 2024 · Dec 31, 2023 $25.39M
Rd Expense FY 2024 · Dec 31, 2023 $53.54M
Net Income FY 2024 · Dec 31, 2023 −$74.56M
Operating Income FY 2024 · Dec 31, 2023 −$78.93M
Stockholders Equity FY 2024 · Dec 31, 2022 $169.32M